Depression Treatment with Deep Transcranial Magnetic Stimulation (TMS)

Katie's Way is revolutionizing depression treatment. Have you been diagnosed with major depressive disorder (MDD)? Have you tried one or more antidepressant medications without relief? If you're struggling to overcome depression, Deep TMS therapy can help you achieve wellbeing.

What is Deep TMS therapy?

Transcranial Magnetic Stimulation, or TMS, is an FDA approved, non-invasive treatment option that offers long-term relief for major depression. This revolutionary treatment uses magnetic fields to stimulate areas of the brain that control mood and are under active in people with depression.

Deep TMS therapy is an effective treatment for depression that is quick, well tolerated and non-invasive.

WIth each therapy session lasting approximately 20 minutes, the treatment can fit easily into your schedule. The treatment has minimal side effects1, and is covered by most private payers.


Achieve Wellbeing


Feel Supported


Function Again

How does Deep TMS Therapy work?

Katie's Way uses cutting technology from BrainsWay to deliver Deep TMS Therapy.

Frequently Asked Questions

Schedule your first TMS appointment today

Call 785-320-2908

     720 Poyntz Avenue, Manhattan, KS 66502

1 Safety Information: Patients should consult with their doctor before undergoing BrainsWayD The most common side effects include headaches and application site pain or discomfort. There is also a very rare risk of seizure associated with the treatment. Patients with metal in or around the head such as in metal plates, implants and stents, should not undergo Deep TMS treatment.

2 Remission Response Rates: In the multicenter trial that led to BrainsWay's FDA clearance for MDD, 1 in 3 medication-resistant patients achieved full remission and 38.4% achieved a positive response. Real life settings have shown significantly better results. Data on file.

3 Indication: BrainsWayD is indicated by the FDA for the treatment of depressive episodes in adult patients suffering from Major Depressive Disorder, who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode. FDA 510(k) No. K 122288.

720 Poyntz Avenue
Manhattan, KS 66502